相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Template-directed synthesis of a small molecule-antisense conjugate targeting an mRNA structure
Yang Liu et al.
BIOORGANIC CHEMISTRY (2014)
Neuronal uptake of tau/pS422 antibody and reduced progression of tau pathology in a mouse model of Alzheimer's disease
Ludovic Collin et al.
BRAIN (2014)
In vivo evaluation of a novel tau imaging tracer for Alzheimer's disease
Victor L. Villemagne et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
Microtubule-associated protein tau as a therapeutic target in Alzheimer's disease
Khalid Iqbal et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2014)
The role of protein glycosylation in Alzheimer disease
Sophia Schedin-Weiss et al.
FEBS JOURNAL (2014)
Tau-Based Therapeutic Approaches for Alzheimer's Disease - A Mini-Review
Allal Boutajangout et al.
GERONTOLOGY (2014)
Acetylation of the KXGS motifs in tau is a critical determinant in modulation of tau aggregation and clearance
Casey Cook et al.
HUMAN MOLECULAR GENETICS (2014)
Specific Targeting of Tau Oligomers in Htau Mice Prevents Cognitive Impairment and Tau Toxicity Following Injection with Brain-Derived Tau Oligomeric Seeds
Diana L. Castillo-Carranza et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
A Neuroprotective Brain-penetrating Endopeptidase Fusion Protein Ameliorates Alzheimer Disease Pathology and Restores Neurogenesis
Brian Spencer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Prion-like Properties of Tau Protein: The Importance of Extracellular Tau as a Therapeutic Target
Brandon B. Holmes et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Neuronal activity regulates extracellular tau in vivo
Kaoru Yamada et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
O-GIcNAc Modification of tau Directly Inhibits Its Aggregation without Perturbing the Conformational Properties of tau Monomers
Scott A. Yuzwa et al.
JOURNAL OF MOLECULAR BIOLOGY (2014)
Passive Immunization with Tau Oligomer Monoclonal Antibody Reverses Tauopathy Phenotypes without Affecting Hyperphosphorylated Neurofibrillary Tangles
Diana L. Castillo-Carranza et al.
JOURNAL OF NEUROSCIENCE (2014)
A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy
Eduardo Tolosa et al.
MOVEMENT DISORDERS (2014)
Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease
Syed Faraz Kazim et al.
NEUROBIOLOGY OF DISEASE (2014)
Increased O-GlcNAcylation reduces pathological tau without affecting its normal phosphorylation in a mouse model of tauopathy
Danielle L. Graham et al.
NEUROPHARMACOLOGY (2014)
Ectosomes: A New Mechanism for Non-Exosomal Secretion of Tau Protein
Simon Dujardin et al.
PLOS ONE (2014)
Tau-induced neurodegeneration: mechanisms and targets
Cindy Beharry et al.
NEUROSCIENCE BULLETIN (2014)
Neural stem cells genetically-modified to express neprilysin reduce pathology in Alzheimer transgenic models
Mathew Blurton-Jones et al.
STEM CELL RESEARCH & THERAPY (2014)
Histone deacetylase 6 inhibition improves memory and reduces total tau levels in a mouse model of tau deposition
Maj-Linda Selenica et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
Fyn kinase inhibition as a novel therapy for Alzheimer's disease
Haakon B. Nygaard et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
Acetylation: a new key to unlock tau's role in neurodegeneration
Casey Cook et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
Assessing THK523 selectivity for tau deposits in Alzheimer's disease and non-Alzheimer's disease tauopathies
Michelle T. Fodero-Tavoletti et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
Protein phosphatase 2A dysfunction in Alzheimer's disease
Jean-Marie Sontag et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2014)
The formation of tau pore-like structures is prevalent and cell specific: possible implications for the disease phenotypes
Cristian A. Lasagna-Reeves et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2014)
Characterization of tau oligomeric seeds in progressive supranuclear palsy
Julia E. Gerson et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2014)
Intraneuronal tau aggregation precedes diffuse plaque deposition, but amyloid-β changes occur before increases of tau in cerebrospinal fluid
Heiko Braak et al.
ACTA NEUROPATHOLOGICA (2013)
Cerebral amyloid PET imaging in Alzheimer's disease
Clifford R. Jack et al.
ACTA NEUROPATHOLOGICA (2013)
Tau protein kinases: Involvement in Alzheimer's disease
Ludovic Martin et al.
AGEING RESEARCH REVIEWS (2013)
Tau immunotherapy: The way to crack the immune code of misfolded protein tau
Michal Novak et al.
Alzheimers & Dementia (2013)
A phase II randomized, double-blind, parallel group, 26-week study of GSK-3 inhibitor tideglusib in Alzheimer's disease (ARGO trial)
Teodoro del Ser et al.
Alzheimers & Dementia (2013)
Acetylated Tau Neuropathology in Sporadic and Hereditary Tauopathies
David J. Irwin et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Prion-Like Templated Misfolding in Tauopathies
Florence Clavaguera et al.
BRAIN PATHOLOGY (2013)
Recombinant soluble neprilysin reduces amyloid-beta accumulation and improves memory impairment in Alzheimer's disease mice
Min Hee Park et al.
BRAIN RESEARCH (2013)
Reducing HDAC6 ameliorates cognitive deficits in a mouse model for Alzheimer's disease
Nambirajan Govindarajan et al.
EMBO MOLECULAR MEDICINE (2013)
Physiological release of endogenous tau is stimulated by neuronal activity
Amy M. Pooler et al.
EMBO REPORTS (2013)
Trans-splicing correction of tau isoform imbalance in a mouse model of tau mis-splicing
Maria Elena Avale et al.
HUMAN MOLECULAR GENETICS (2013)
Antibody Uptake into Neurons Occurs Primarily via Clathrin-dependent Fcγ Receptor Endocytosis and Is a Prerequisite for Acute Tau Protein Clearance
Erin E. Congdon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Two Novel Tau Antibodies Targeting the 396/404 Region Are Primarily Taken Up by Neurons and Reduce Tau Protein Pathology
Jiaping Gu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Therapeutic strategies for tau mediated neurodegeneration
Yasumasa Yoshiyama et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
Reversal of Neurofibrillary Tangles and Tau-Associated Phenotype in the rTgTauEC Model of Early Alzheimer's Disease
Manuela Polydoro et al.
JOURNAL OF NEUROSCIENCE (2013)
Antisense Reduction of Tau in Adult Mice Protects against Seizures
Sarah L. DeVos et al.
JOURNAL OF NEUROSCIENCE (2013)
Novel 18F-Labeled Arylquinoline Derivatives for Noninvasive Imaging of Tau Pathology in Alzheimer Disease
Nobuyuki Okamura et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Age-appropriate cognition and subtle dopamine-independent motor deficits in aged Tau knockout mice
Meaghan Morris et al.
NEUROBIOLOGY OF AGING (2013)
Anti-Tau Antibodies that Block Tau Aggregate Seeding In Vitro Markedly Decrease Pathology and Improve Cognition In Vivo
Kiran Yanamandra et al.
NEURON (2013)
Imaging of Tau Pathology in a Tauopathy Mouse Model and in Alzheimer Patients Compared to Normal Controls
Masahiro Maruyama et al.
NEURON (2013)
Tau Passive Immunotherapy in Mutant P301L Mice: Antibody Affinity versus Specificity
Cristina d'Abramo et al.
PLOS ONE (2013)
Efficacy and Safety of A Liposome-Based Vaccine against Protein Tau, Assessed in Tau.P301L Mice That Model Tauopathy
Clara Theunis et al.
PLOS ONE (2013)
Prions, prionoids and pathogenic proteins in Alzheimer disease
Karen H. Ashe et al.
PRION (2013)
Alzheimer disease A tale of two prions
Justin M. Nussbaum et al.
PRION (2013)
Cancer cell exosomes depend on cell-surface heparan sulfate proteoglycans for their internalization and functional activity
Helena C. Christianson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds
Brandon B. Holmes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Propagation of tau pathology in Alzheimer's disease: identification of novel therapeutic targets
Amy M. Pooler et al.
ALZHEIMERS RESEARCH & THERAPY (2013)
Formation and propagation of tau oligomeric seeds
Julia E. Gerson et al.
FRONTIERS IN NEUROLOGY (2013)
HDAC6: Physiological function and its selective inhibitors for cancer treatment
Penghui Yang et al.
DRUG DISCOVERIES AND THERAPEUTICS (2013)
Selective tau tyrosine nitration in non-AD tauopathies
Juan F. Reyes et al.
ACTA NEUROPATHOLOGICA (2012)
The MAPT H1 haplotype is associated with tangle-predominant dementia
Ismael Santa-Maria et al.
ACTA NEUROPATHOLOGICA (2012)
The Synaptic Accumulation of Hyperphosphorylated Tau Oligomers in Alzheimer Disease Is Associated With Dysfunction of the Ubiquitin-Proteasome System
Hwan-Ching Tai et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Mechanism of Amyloid Removal in Patients With Alzheimer Disease Treated With Gantenerumab
Susanne Ostrowitzki et al.
ARCHIVES OF NEUROLOGY (2012)
Towards understanding the phosphorylation code of tau
Guy Lippens et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2012)
The self-perpetuating tau truncation circle
Norbert Zilka et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2012)
Interaction of Tau Protein with Model Lipid Membranes Induces Tau Structural Compaction and Membrane Disruption
Emmalee M. Jones et al.
BIOCHEMISTRY (2012)
Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies
David J. Irwin et al.
BRAIN (2012)
Tau-targeted treatment strategies in Alzheimer's disease
Juergen Goetz et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Directed Evolution of Highly Selective Proteases by Using a Novel FACS-Based Screen that Capitalizes on the p53 Regulator MDM2
Tae Hyeon Yoo et al.
CHEMBIOCHEM (2012)
Targeting Phospho-Ser422 by Active Tau Immunotherapy in the THY-Tau22 Mouse Model: A Suitable Therapeutic Approach
Laetitia Troquier et al.
CURRENT ALZHEIMER RESEARCH (2012)
Limited cleavage of tau with matrix-metalloproteinase MMP-9, but not MMP-3, enhances tau oligomer formation
G. Nuebling et al.
EXPERIMENTAL NEUROLOGY (2012)
Identification of oligomers at early stages of tau aggregation in Alzheimer's disease
Cristian A. Lasagna-Reeves et al.
FASEB JOURNAL (2012)
Exosome-associated Tau Is Secreted in Tauopathy Models and Is Selectively Phosphorylated in Cerebrospinal Fluid in Early Alzheimer Disease
Sudad Saman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
Peter T. Nelson et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2012)
An Effector-Reduced Anti-β-Amyloid (Aβ) Antibody with Unique Aβ Binding Properties Promotes Neuroprotection and Glial Engulfment of Aβ
Oskar Adolfsson et al.
JOURNAL OF NEUROSCIENCE (2012)
Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation
Scott A. Yuzwa et al.
NATURE CHEMICAL BIOLOGY (2012)
Dynamic association of tau with neuronal membranes is regulated by phosphorylation
Amy M. Pooler et al.
NEUROBIOLOGY OF AGING (2012)
Targeting a pre-mRNA structure with bipartite antisense molecules modulates tau alternative splicing
Eleanor Peacey et al.
NUCLEIC ACIDS RESEARCH (2012)
Hyperphosphorylation and Cleavage at D421 Enhance Tau Secretion
Vanessa Plouffe et al.
PLOS ONE (2012)
Differential Effects of an O-GlcNAcase Inhibitor on Tau Phosphorylation
Yang Yu et al.
PLOS ONE (2012)
The pathological process underlying Alzheimer's disease in individuals under thirty
Heiko Braak et al.
ACTA NEUROPATHOLOGICA (2011)
Tyrosine Nitration within the Pro line-Rich Region of Tau in Alzheimer's Disease
Juan F. Reyes et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease
Michelle T. Fodero-Tavoletti et al.
BRAIN (2011)
Phosphoprotein phosphatase 2A: a novel druggable target for Alzheimer's disease
Michael Voronkov et al.
FUTURE MEDICINAL CHEMISTRY (2011)
Brief Update on Different Roles of Tau in Neurodegeneration
Arne Ittner et al.
IUBMB LIFE (2011)
Passive Immunization with Anti-Tau Antibodies in Two Transgenic Models REDUCTION OF TAU PATHOLOGY AND DELAY OF DISEASE PROGRESSION
Xiyun Chai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Are Tangles as Toxic as They Look?
Tara L. Spires-Jones et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2011)
In Vivo Microdialysis Reveals Age-Dependent Decrease of Brain Interstitial Fluid Tau Levels in P301S Human Tau Transgenic Mice
Kaoru Yamada et al.
JOURNAL OF NEUROSCIENCE (2011)
Tau-Targeted Immunization Impedes Progression of Neurofibrillary Histopathology in Aged P301L Tau Transgenic Mice
Mian Bi et al.
PLOS ONE (2011)
The acetylation of tau inhibits its function and promotes pathological tau aggregation
Todd J. Cohen et al.
NATURE COMMUNICATIONS (2011)
Mechanistic Studies of Antibody-Mediated Clearance of Tau Aggregates Using an ex vivo Brain Slice Model
Pavan K. Krishnamurthy et al.
Frontiers in Psychiatry (2011)
Tau cleavage and tau aggregation in neurodegenerative disease
Diane P. Hanger et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2010)
Proteolytic processing of tau
Yipeng Wang et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2010)
Tau Truncation is a Productive Posttranslational Modification of Neurofibrillary Degeneration in Alzheimer's Disease
B. Kovacech et al.
CURRENT ALZHEIMER RESEARCH (2010)
Efficacy and safety of immunization with phosphorylated tau against neurofibrillary tangles in mice
Moran Boimel et al.
EXPERIMENTAL NEUROLOGY (2010)
Secretion of human tau fragments resembling CSF-tau in Alzheimer's disease is modulated by the presence of the exon 2 insert
WonHee Kim et al.
FEBS LETTERS (2010)
Phosphorylation of Tau at Thr212, Thr231, and Ser262 Combined Causes Neurodegeneration
Alejandra D. Alonso et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Caspase activation precedes and leads to tangles
Alix de Calignon et al.
NATURE (2010)
Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy
Sang-Won Min et al.
NEURON (2010)
Tau Reduction Prevents Aβ-Induced Defects in Axonal Transport
Keith A. Vossel et al.
SCIENCE (2010)
Engineering next generation proteases
Mark Pogson et al.
CURRENT OPINION IN BIOTECHNOLOGY (2009)
Correction of tau mis-splicing caused by FTDP-17 MAPT mutations by spliceosome-mediated RNA trans-splicing
Teresa Rodriguez-Martin et al.
HUMAN MOLECULAR GENETICS (2009)
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
S. Salloway et al.
NEUROLOGY (2009)
O3-04-07: Tau aggregation inhibitor (TAI) therapy with rember™ arrests disease progression in mild and moderate Alzheimer's disease over 50 weeks
Claude M. Wischik et al.
Alzheimers & Dementia (2008)
O-GlcNAcylation modulates the self-aggregation ability of the fourth microtubule-binding repeat of tau
Chun-Hui Yu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
The natively unfolded character of Tau and its aggregation to Alzheimer-like paired helical filaments
Sadasivam Jeganathan et al.
BIOCHEMISTRY (2008)
Mechanism of tau-induced neurodegeneration in Alzheimer disease and related tauopathies
Alejandra del C. Alonso et al.
CURRENT ALZHEIMER RESEARCH (2008)
Cleavage and conformational changes of tau protein follow phosphorylation during Alzheimer's disease
Siddhartha Mondragon-Rodriguez et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2008)
Proline-directed Pseudo-phosphorylation at AT8 and PHF1 Epitopes Induces a Compaction of the Paperclip Folding of Tau and Generates a Pathological (MC-1) Conformation
Sadasivam Jeganathan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Histone deacetylase 6 interacts with the microtubule-associated protein tau
Huiping Ding et al.
JOURNAL OF NEUROCHEMISTRY (2008)
The potential for β-structure in the repeat domain of Tau protein determines aggregation, synaptic decay, neuronal loss, and coassembly with endogenous Tau in inducible mouse models of tauopathy
Maria-Magdalena Mocanu et al.
JOURNAL OF NEUROSCIENCE (2008)
Structure of a protein phosphatase 2A holoenzyme: Insights into B55-mediated Tau dephosphorylation
Yanhui Xu et al.
MOLECULAR CELL (2008)
Animal models of Alzheimer's disease and frontotemporal dementia
Jurgen Gotz et al.
NATURE REVIEWS NEUROSCIENCE (2008)
Haplotype-specific expression of the N-terminal exons 2 and 3 at the human MAPT locus
Tara M. Caffrey et al.
NEUROBIOLOGY OF AGING (2008)
Identification of tau stem loop RNA stabilizers
Christine P. Donahue et al.
JOURNAL OF BIOMOLECULAR SCREENING (2007)
Immunotherapy targeting pathological tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements
Ayodeji A. Asuni et al.
JOURNAL OF NEUROSCIENCE (2007)
Reducing endogenous tau ameliorates amyloid β-induced deficits in an Alzheimer's disease mouse model
Erik D. Roberson et al.
SCIENCE (2007)
The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts
Amanda J. Myers et al.
NEUROBIOLOGY OF DISEASE (2007)
Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration
Jian-Zhi Wang et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
Hereditary frontotemporal dementia caused by Tau gene mutations
John van Swieten et al.
BRAIN PATHOLOGY (2007)
A decade of tau transgenic animal models and beyond
Juergen Goetz et al.
BRAIN PATHOLOGY (2007)
Region-specific dissociation of neuronal loss and neurofibrillary pathology in a mouse model of tauopathy
TL Spires et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Tau therapeutic strategies for the treatment of Alzheimer's disease
Ian Churcher
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2006)
Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L)
M Ramsden et al.
JOURNAL OF NEUROSCIENCE (2005)
The H1c haplotype at the MAPT locus is associated with Alzheimer's disease
AJ Myers et al.
HUMAN MOLECULAR GENETICS (2005)
Tau suppression in a neurodegenerative mouse model improves memory function
K SantaCruz et al.
SCIENCE (2005)
Tau truncation during neurofibrillary tangle evolution in Alzheimer's disease
AL Guillozet-Bongaarts et al.
NEUROBIOLOGY OF AGING (2005)
The role of caspase cleavage of tau in Alzheimer disease neuropathology
CW Cotman et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2005)
Microtubule-binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model
B Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Tau aggregation is driven by a transition from random coil to beta sheet structure
M von Bergen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2005)
Tau gene alternative splicing: expression patterns, regulation and modulation of function in normal brain and neurodegenerative diseases
A Andreadis
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2005)
Accepting its random coil nature allows a partial NMR assignment of the neuronal Tau protein
C Smet et al.
CHEMBIOCHEM (2004)
O-GlcNAcylation regulates phosphorylation of tau: A mechanism involved in Alzheimer's disease
F Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Neuron loss from the hippocampus of Alzheimer's disease exceeds extracellular neurofibrillary tangle formation
JJ Kril et al.
ACTA NEUROPATHOLOGICA (2002)
Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease
JC Augustinack et al.
ACTA NEUROPATHOLOGICA (2002)
Hyperphosphorylation induces self-assembly of τ into tangles of paired helical filaments/straight filaments
AD Alonso et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
PP2A mRNA expression is quantitatively decreased in Alzheimer's disease hippocampus
V Vogelsberg-Ragaglia et al.
EXPERIMENTAL NEUROLOGY (2001)
Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
F Bard et al.
NATURE MEDICINE (2000)
Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain - Implications for neurofibrillary degeneration in Alzheimer's disease
CX Gong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
